Thomas J. Stegmann
Institutional Affiliation
- CardioVascular BioTherapeutics, Inc.; Phage Biotechnology Corporation
Specialty
- Adult Cardiac Surgery
- General Thoracic Surgery
- Peripheral Vascular Surgery
Background
- Studies of Human Medicine: Final Examination - 1974
- Doctor Thesis (Dissertation): summa cum laude - 1974
- Price of Faculty (University of Heidelberg) - 1974
- Hannover Medical School (MHH) 1976 - 1984; Prof.Borst, Prof.Pichlmayr, Prof.Tscherne
- Licenses: General Surgery - 1982, Cardiothoracic & Vascular Surgery - 1983
- Rudolf-Nissen-Memorial-Award - 1982; Appointment Professor of Surgery - 1989
- Head of the Dept. of Thoracic & Cardiovascular Surgery, Fulda Medical Center (1984-2006)
- Visiting Professor at McGill University, Montreal, Canada (1998); Faculty Member MHH (since 1982)
- Honorary Member - RIDEAU Institute, Canada (since 1998); Member - Ukrainian Academy of Med. Sciences
- CMO & Board Member, Cardiovascular BioTherapeutics, Inc.; CEO & President, Phage Biotechnology Corp.
Interests
- Heart & Lung Transplantation
- Coronary Bypass Surgery
- Surgery of the Aorta
- Aortic Dissection
- Abdominal Aortic Aneurysm - Surgical Treatment
- Angiogenesis, Myogenesis
- Angiogenic Growth Factors
- Angiogenic Therapy of Coronary Heart Disease
- History
- Sailing
Last Modified: 3-Feb-2009
